trending Market Intelligence /marketintelligence/en/news-insights/trending/F89OlOE4mhia3PDPR73IAQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

NBK Capital buys AfricInvest's stake in Polymedic

StreetTalk – Episode 70: Banks' Liquidity Conundrum Could Fuel M&A Activity

Street Talk Episode 70 - Banks' Liquidity Conundrum Could Fuel M&A Activity

StreetTalk – Episode 69: Banks left with pockets full of cash and few places to go

Street Talk – Episode 69: Banks left with pockets full of cash and few places to go

NBK Capital buys AfricInvest's stake in Polymedic

NBK Capital Partners acquired the stake of Tunisian private equity firm AfricInvest in pharmaceutical company Polymedic SA, according to Africa Global Funds.

The exit of AfricInvest's Maghreb Private Equity Fund III in Polymedic enables Dubai, United Arab Emirates-based NBK Capital and Jordan's Foursan Group-owned Foursan Capital Partners private equity fund to own a majority stake in Polymedic.

Mohamed Houbachi, Polymedic CEO, will remain in position and will keep a significant stake in the company, according to the report.

The Casablanca, Morocco-based generics manufacturing company specializes in producing and marketing medicines, owning a portfolio of over 200 registered products across 12 therapeutic areas. It also manufactures originator drugs and other generic medicines for pharmaceutical companies such as Aventis, Leo, Bayer and Schering.

Attijariwafa Bank Morocco and Attijariwafa Bank Middle East (Dubai) acted as arranger, facility agent and book runner of the transaction financing, advised by Naciri & Associes – Allen & Overy.

Freshfields Bruckhaus Deringer, Asafo & Co., Dentons and Clifford Chance provided NBK Capital Partners and Polymedic legal advice.